Amedisys (AMED)
(Real Time Quote from BATS)
$91.02 USD
-0.03 (-0.03%)
Updated Apr 25, 2024 12:00 PM ET
2-Buy of 5 2
B Value B Growth D Momentum B VGM
Balance Sheet
Fiscal Year End for Amedisys, Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 139 | 54 | 46 | 83 | 96 |
Receivables | 313 | 297 | 275 | 255 | 238 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 |
Other Current Assets | 45 | 38 | 36 | 23 | 16 |
Total Current Assets | 497 | 389 | 357 | 362 | 351 |
Net Property & Equipment | 42 | 16 | 18 | 24 | 28 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 48 | 21 |
Intangibles | 1,347 | 1,389 | 1,307 | 1,007 | 723 |
Deposits & Other Assets | 85 | 80 | 73 | 33 | 55 |
Total Assets | 2,060 | 1,976 | 1,857 | 1,567 | 1,263 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 28 | 44 | 38 | 43 | 31 |
Current Portion Long-Term Debt | 36 | 16 | 13 | 11 | 10 |
Current Portion Capital Leases | 26 | 0 | 0 | 0 | 0 |
Accrued Expenses | 277 | 263 | 292 | 313 | 258 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 106 | 0 | 0 | 60 | 0 |
Total Current Liabilities | 474 | 356 | 374 | 456 | 327 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 41 | 20 | 0 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 362 | 419 | 432 | 205 | 232 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 1 | 5 | 5 | 34 | 6 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 940 | 870 | 881 | 756 | 621 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 787 | 755 | 728 | 698 | 645 |
Retained Earnings | 748 | 758 | 639 | 430 | 246 |
Other Equity | 53 | 55 | 45 | 2 | 1 |
Treasury Stock | 469 | 461 | 436 | 319 | 251 |
Total Shareholder's Equity | 1,120 | 1,107 | 976 | 811 | 642 |
Total Liabilities & Shareholder's Equity | 2,060 | 1,976 | 1,857 | 1,567 | 1,263 |
Total Common Equity | 1,120 | 1,107 | 976 | 811 | 642 |
Shares Outstanding | 32.60 | 32.40 | 32.60 | 32.80 | 32.20 |
Book Value Per Share | 34.35 | 34.15 | 29.95 | 24.72 | 19.92 |
Fiscal Year End for Amedisys, Inc falls in the month of December.
All items in Millions except Per Share data.
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | 139 | 94 | 111 | 69 |
Receivables | NA | 313 | 320 | 279 | 294 |
Notes Receivable | NA | 0 | 0 | 0 | 0 |
Inventories | NA | 0 | 0 | 0 | 0 |
Other Current Assets | NA | 45 | 54 | 37 | 42 |
Total Current Assets | NA | 497 | 467 | 427 | 406 |
Net Property & Equipment | NA | 42 | 40 | 36 | 33 |
Investments & Advances | NA | 0 | 0 | 0 | 0 |
Other Non-Current Assets | NA | 0 | 0 | 0 | 0 |
Deferred Charges | NA | 0 | 0 | 0 | 0 |
Intangibles | NA | 1,347 | 1,348 | 1,349 | 1,345 |
Deposits & Other Assets | NA | 85 | 84 | 85 | 78 |
Total Assets | NA | 2,060 | 2,027 | 1,982 | 1,947 |
Liabilities & Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Notes Payable | NA | 0 | 0 | 0 | 0 |
Accounts Payable | NA | 28 | 35 | 39 | 40 |
Current Portion Long-Term Debt | NA | 36 | 35 | 31 | 27 |
Current Portion Capital Leases | NA | 26 | 0 | 0 | 0 |
Accrued Expenses | NA | 277 | 266 | 261 | 261 |
Income Taxes Payable | NA | 0 | 0 | 0 | 0 |
Other Current Liabilities | NA | 106 | 106 | 106 | 0 |
Total Current Liabilities | NA | 474 | 468 | 462 | 353 |
Mortgages | NA | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | NA | 41 | 35 | 28 | 23 |
Convertible Debt | NA | 0 | 0 | 0 | 0 |
Long-Term Debt | NA | 362 | 367 | 370 | 373 |
Non-Current Capital Leases | NA | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | NA | 2 | 2 | 5 | |
Minority Interest (Liabilities) | NA | 0 | 0 | 0 | 0 |
Total Liabilities | NA | 940 | 934 | 922 | 814 |
Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Preferred Stock | NA | 0 | 0 | 0 | 0 |
Common Stock (Par) | NA | 0 | 0 | 0 | 0 |
Capital Surplus | NA | 787 | 777 | 769 | 759 |
Retained Earnings | NA | 748 | 729 | 703 | 783 |
Other Equity | NA | 53 | 54 | 54 | 54 |
Treasury Stock | NA | 469 | 466 | 465 | 463 |
Total Shareholder's Equity | NA | 1,120 | 1,094 | 1,061 | 1,133 |
Total Liabilities & Shareholder's Equity | NA | 2,060 | 2,027 | 1,982 | 1,947 |
Total Common Equity | 0 | 1,120 | 1,094 | 1,061 | 1,133 |
Shares Outstanding | 32.60 | 32.60 | 32.60 | 32.60 | 32.50 |
Book Value Per Share | 0.00 | 34.35 | 33.54 | 32.54 | 34.87 |